SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-08-000064
Filing Date
2008-08-08
Accepted
2008-08-08 14:48:14
Documents
8
Period of Report
2008-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k_080808.htm 8-K 14252
2 ex99.htm EX-99 30000
3 GRAPHIC img1.gif GRAPHIC 6739
4 GRAPHIC img2.gif GRAPHIC 9627
5 GRAPHIC img3.gif GRAPHIC 14130
6 GRAPHIC img4.gif GRAPHIC 13638
7 GRAPHIC img5.jpg GRAPHIC 4620
8 GRAPHIC img6.jpg GRAPHIC 1914
  Complete submission text file 0001367644-08-000064.txt   116370
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 081002044
SIC: 2834 Pharmaceutical Preparations